Marijke Vroomen Durning, RN | Authors


Lessons Learned From COVID-19— 1 Year Later

April 18, 2021

The pandemic brought about by severe acute respiratory syndrome coronavirus 2 has put some aspects of life on hold for over a year now. However, for people living with serious and potentially fatal illnesses, putting life on hold is not an option.

NCI-MATCH Trial Explores Tumor-Agnostic Approach

February 03, 2021

A tumor-agnostic approach in which treatment is developed based on a tumor’s genetic and molecular features without regard to the cancer type or primary tumor location in the body, is the focus of the National Cancer Institute -MATCH trial.

Protocol Management, Off-the-Shelf Therapies Help Bring CAR T Into More Settings

May 12, 2020

Relevant professional meetings and oncology publications exploded with research and news about chimeric antigen receptor T cells, and this cellular therapy strategy is now being explored across hematologic and solid malignancies.